Patent ID: 6589997
Filing Date: 2003-07-08
Classification: A61K

Abstract:
A method for modulating HGF/SF activity in a mammal comprising administering to said mammal an effective HGF/SF activity modulating amount of a compound with the general formula IV: whereinR1 is a phenyl group substituted with hydrogen, a halogen, C1 to C4 alkyl, or C1 to C4 alkyloxy, or is a heteroaryl group selected from the group consisting of 4-bromo-2-thienyl, 4-pyridyl, 2-furyl, 3-thienyl, optionally substituted with halogens and/or C1 to C4 alkyl; and R2 is one or more hydrogen, C1 to C4 alkyl, halogen, or C1 to C4 alkyloxy groups.